Addus HomeCare Co. (NASDAQ:ADUS – Get Free Report) has earned a consensus rating of “Moderate Buy” from the nine analysts that are covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating and eight have issued a buy rating on the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $116.25.
A number of equities analysts recently issued reports on the company. Bank of America increased their price objective on Addus HomeCare from $115.00 to $118.00 and gave the stock a “buy” rating in a report on Tuesday, May 7th. Macquarie started coverage on Addus HomeCare in a report on Friday, June 28th. They set an “outperform” rating and a $136.00 price target on the stock. Barclays downgraded shares of Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price objective for the company. in a report on Tuesday, April 23rd. StockNews.com lowered shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 7th. Finally, Oppenheimer boosted their price target on shares of Addus HomeCare from $118.00 to $130.00 and gave the stock an “outperform” rating in a research report on Friday, June 7th.
Check Out Our Latest Analysis on ADUS
Insider Transactions at Addus HomeCare
Institutional Trading of Addus HomeCare
Several institutional investors and hedge funds have recently bought and sold shares of ADUS. Boston Partners purchased a new position in shares of Addus HomeCare in the first quarter worth approximately $12,215,000. Lord Abbett & CO. LLC purchased a new position in Addus HomeCare during the 1st quarter worth approximately $8,274,000. Allianz Asset Management GmbH acquired a new stake in Addus HomeCare during the 4th quarter valued at $5,667,000. Vanguard Group Inc. lifted its holdings in shares of Addus HomeCare by 4.9% in the third quarter. Vanguard Group Inc. now owns 1,218,564 shares of the company’s stock valued at $103,809,000 after purchasing an additional 57,040 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. boosted its position in shares of Addus HomeCare by 127.7% in the third quarter. Jacobs Levy Equity Management Inc. now owns 100,158 shares of the company’s stock worth $8,532,000 after buying an additional 56,171 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.
Addus HomeCare Stock Performance
ADUS stock opened at $120.90 on Wednesday. The stock’s fifty day moving average is $114.21 and its two-hundred day moving average is $101.56. The stock has a market capitalization of $2.19 billion, a price-to-earnings ratio of 30.00, a PEG ratio of 2.33 and a beta of 1.01. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.35 and a current ratio of 1.35. Addus HomeCare has a 1 year low of $78.35 and a 1 year high of $121.42.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last posted its earnings results on Monday, May 6th. The company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.97 by $0.24. Addus HomeCare had a net margin of 6.04% and a return on equity of 10.03%. The firm had revenue of $280.70 million during the quarter, compared to analyst estimates of $279.49 million. During the same period in the previous year, the business posted $0.84 EPS. Addus HomeCare’s revenue was up 11.6% on a year-over-year basis. On average, research analysts predict that Addus HomeCare will post 4.36 EPS for the current year.
About Addus HomeCare
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Recommended Stories
- Five stocks we like better than Addus HomeCare
- What Is WallStreetBets and What Stocks Are They Targeting?
- Top 3 Defense Stocks That Should Be on Your Radar
- Why Invest in High-Yield Dividend Stocks?
- Why This Banking Stock Might Be Nearing the Bottom of Its Cycle
- How to Invest in the Best Canadian Stocks
- MarketBeat Week in Review – 7/8 – 7/12
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.